37 results
8-K
EX-99.1
NMRA
Neumora Therapeutics Inc.
7 May 24
Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
7:15am
enrolling the registrational Phase 3 KOASTAL program, which is designed to evaluate the efficacy and safety of navacaprant monotherapy for the treatment … once-daily dosing profile.
Neumora is advancing pre-clinical safety and toxicology work with its additional M4 PAM compounds and expects to submit
10-K
2023 FY
NMRA
Neumora Therapeutics Inc.
7 Mar 24
Annual report
4:05pm
related thereto;
the ability of our clinical trials to demonstrate safety and efficacy of our product candidates, and other positive results;
our … safety of navacaprant which were all initiated in 2023. We anticipate releasing topline results from the KOASTAL-1 study in the second half of 2024
8-K
EX-99.1
NMRA
Neumora Therapeutics Inc.
7 Mar 24
Neumora Therapeutics Reports Fourth Quarter and Full Year 2023
7:08am
program, which is designed to evaluate the efficacy and safety of navacaprant monotherapy for the treatment of MDD. KOASTAL-1, KOASTAL-2, and KOASTAL-3
8-K
EX-99.1
NMRA
Neumora Therapeutics Inc.
8 Jan 24
Regulation FD Disclosure
8:32am
including anhedonia, well-tolerated safety profile NDA submission in MDD monotherapy (2025) Strong rationale in BPD Topline data readout from Phase 2 … Efficacy in Symptoms of Depression and Anhedonia HAMD-17 Week 0 Week 4 Week 8 Safety profile with significant advantages 0 over existing treatment options
10-Q
nvo2l
1 Nov 23
Quarterly report
4:05pm
8-K
EX-99.1
q87pg
1 Nov 23
Neumora Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
4:01pm
8-K
EX-3.2
s3vm y4b02t
19 Sep 23
Amendments to Articles of Incorporation or Bylaws
4:16pm
424B4
kh5l7fe 4lcl
18 Sep 23
Prospectus supplement with pricing info
4:12pm
S-1/A
EX-1.1
s280b2 iuupesmyt1q5
11 Sep 23
IPO registration (amended)
6:07am
S-1/A
1v08if
11 Sep 23
IPO registration (amended)
6:07am
S-1
EX-3.4
7igj6r8dd7
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.2
hxvy68n2w4wbi n1n
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.18
d055wvyg7 b3gv
25 Aug 23
IPO registration
5:03pm
S-1
EX-2.2
ov4uoaxjx5yxh
25 Aug 23
IPO registration
5:03pm
S-1
yre4i7xnywjk6a04o
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.14
ccnm2r6lir7 j62x
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.3
16mrca gag
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.5
plujy
25 Aug 23
IPO registration
5:03pm
S-1
EX-2.1
6v7iuww
25 Aug 23
IPO registration
5:03pm